| Revision as of 00:11, 25 July 2017 view sourceFrietjes (talk | contribs)Autopatrolled, Extended confirmed users, Template editors1,000,827 edits bypass wrapper← Previous edit |
Revision as of 15:19, 11 August 2017 view source AlyInWikiWonderland (talk | contribs)Autopatrolled, Extended confirmed users81,666 editsNo edit summaryNext edit → |
| Line 10: |
Line 10: |
|
| list1 = {{Navbox|subgroup |
|
| list1 = {{Navbox|subgroup |
|
|
|
|
|
| group1 = ]s |
|
| group1 = {{abbrlink|SSRIs|Selective serotonin reuptake inhibitors}} |
|
| list1 = |
|
| list1 = |
|
* ] |
|
* ] |
| Line 21: |
Line 21: |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
|
|
|
|
| group2 = ]s |
|
| group2 = {{abbrlink|SNRIs|Serotonin–norepinephrine reuptake inhibitors}} |
|
| list2 = |
|
| list2 = |
|
* ] |
|
* ] |
| Line 30: |
Line 30: |
|
* ] |
|
* ] |
|
|
|
|
|
| group3 = ]s |
|
| group3 = {{abbrlink|NRIs|Norepinephrine reuptake inhibitors}} |
|
| list3 = |
|
| list3 = |
|
* ] |
|
* ] |
| Line 36: |
Line 36: |
|
* ] |
|
* ] |
|
|
|
|
|
| group4 = ]s |
|
| group4 = {{abbrlink|NDRIs|Norepinephrine–dopamine reuptake inhibitors}} |
|
| list4 = |
|
| list4 = |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
| Line 42: |
Line 42: |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
|
|
|
|
|
| group5 = ]s |
|
| group5 = {{abbrlink|NaSSAs|Noradrenergic and specific serotonergic antidepressants}} |
|
| list5 = |
|
| list5 = |
|
* ] |
|
* ] |
| Line 48: |
Line 48: |
|
* ] |
|
* ] |
|
|
|
|
|
| group6 = ]s |
|
| group6 = {{abbrlink|SARIs|Serotonin antagonist and reuptake inhibitors}} |
|
| list6 = |
|
| list6 = |
|
* ] |
|
* ] |
| Line 54: |
Line 54: |
|
* ] |
|
* ] |
|
|
|
|
|
| group7 = ]s |
|
| group7 = {{abbrlink|SMS|Serotonin modulator and stimulators}} |
|
| list7 = |
|
| list7 = |
|
* ] |
|
* ] |
| Line 81: |
Line 81: |
|
| list2 = {{Navbox|subgroup |
|
| list2 = {{Navbox|subgroup |
|
|
|
|
|
| group1 = ]s |
|
| group1 = {{abbrlink|TCAs|Tricyclic antidepressants}} |
|
| list1 = |
|
| list1 = |
|
* ]<sup>‡</sup> |
|
* ]<sup>‡</sup> |
| Line 111: |
Line 111: |
|
* ] |
|
* ] |
|
|
|
|
|
| group2 = ]s |
|
| group2 = {{abbrlink|TeCAs|Tetracyclic antidepressants}} |
|
| list2 = |
|
| list2 = |
|
* ] |
|
* ] |
| Line 152: |
Line 152: |
|
* ''Mixed:'' ] |
|
* ''Mixed:'' ] |
|
|
|
|
|
| group2 = MAO<sub>A</sub>-selective |
|
| group2 = {{abbrlink|MAO<sub>A</sub>|Monoamine oxidase A}}-selective |
|
| list2 = |
|
| list2 = |
|
|
|
|
| Line 163: |
Line 163: |
|
* ] |
|
* ] |
|
|
|
|
|
| group3 = MAO<sub>B</sub>-Selective |
|
| group3 = {{abbrlink|MAO<sub>B</sub>|Monoamine oxidase B}}-selective |
|
| list3 = |
|
| list3 = |
|
* ''Irreversible:'' ] |
|
* ''Irreversible:'' ] |
| Line 180: |
Line 180: |
|
| group5 = Miscellaneous |
|
| group5 = Miscellaneous |
|
| list5 = |
|
| list5 = |
|
* ] |
|
* ] |
|
* ] |
|
* ] |
|
* ] |
|
* ] |
|
* ] |
|
* ] |
|
* ] |
|
* ] |